Skip to content

DocGo DCGO Finance Lease, Right-of-Use Asset, after Accumulated Amortization

Finance Lease, Right-of-Use Asset, after Accumulated Amortization at other companies

Nutex Health Inc. logo
Nutex Health Inc.NUTX
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseRightOfUseAsset.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's finance lease, right-of-use asset, after accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's finance lease, right-of-use asset, after accumulated amortization?
DocGo (DCGO) reported finance lease, right-of-use asset, after accumulated amortization of $18.12M in Q1 2026.
How has DocGo's finance lease, right-of-use asset, after accumulated amortization changed year-over-year?
DocGo's finance lease, right-of-use asset, after accumulated amortization increased by 5.6% year-over-year, from $17.16M to $18.12M.
What is the long-term trend for DocGo's finance lease, right-of-use asset, after accumulated amortization?
Over 5 years (2020 to 2025), DocGo's finance lease, right-of-use asset, after accumulated amortization has grown at a 20.0% compound annual growth rate (CAGR), from $7M to $17.42M.